Loading...
Loading...
CryoCove Guide
Chronic fatigue is not laziness, not depression, and not “all in your head.” It is a multi-system biological dysfunction with measurable markers and evidence-based solutions. This guide covers mitochondrial support, HPA axis restoration, immune modulation, energy metabolism, and a staged recovery protocol built for real results.
6
Mitochondrial targets
9
Diagnostic blood tests
8
Evidence-based supplements
4
Recovery phases
Understanding the Condition
Chronic Fatigue Syndrome (CFS), also called Myalgic Encephalomyelitis (ME), is a complex, multi-system disease affecting an estimated 836,000 to 2.5 million Americans. Despite decades of dismissal, research has now identified clear biological abnormalities.
CFS/ME is not a diagnosis of exclusion or a wastebasket term. The 2015 Institute of Medicine (now National Academy of Medicine) report established clear diagnostic criteria and renamed the condition Systemic Exertion Intolerance Disease (SEID) to better reflect its core feature: a pathological inability to tolerate exertion.
The condition typically begins after an acute trigger — viral infection (EBV, HHV-6, enteroviruses), bacterial infection, physical trauma, surgery, severe psychological stress, or environmental exposure (mold, toxins). The onset is usually sudden: patients can often identify the exact week their health changed. Post-COVID chronic fatigue (Long COVID) has brought unprecedented attention to this mechanism, as millions experienced the same post-infectious fatigue cascade that CFS/ME researchers have studied for decades.
The underlying biology involves dysfunction across multiple systems simultaneously: mitochondrial energy production, the HPA (hypothalamic-pituitary-adrenal) stress axis, immune regulation, autonomic nervous system control, and gut barrier integrity. This multi-system nature explains why no single treatment works — and why a comprehensive, staged approach is essential.
A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for more than 6 months and is accompanied by fatigue that is often profound, is of new or definite onset (not lifelong), is not the result of ongoing excessive exertion, and is not substantially alleviated by rest.
Worsening of symptoms following physical, mental, or emotional exertion that would not have caused a problem before illness. PEM often delays onset by 12-72 hours after exertion, is disproportionate to the exertion, and may take days, weeks, or longer to resolve. This is the hallmark feature that distinguishes CFS/ME from other fatigue conditions.
Patients feel unrefreshed after a full night of sleep. Sleep studies often show reduced deep sleep (N3 stage), alpha-wave intrusion during delta sleep (alpha-delta sleep anomaly), and disrupted sleep architecture. Patients may sleep 8-10+ hours and awaken feeling as exhausted as when they went to bed.
Cognitive impairment: problems with thinking, memory, executive function, information processing, and attention ('brain fog'). Often worsened by exertion, stress, or time pressure. OR Orthostatic intolerance: worsening of symptoms upon standing upright, with improvement when lying down. Includes POTS (postural orthostatic tachycardia syndrome), neurally mediated hypotension, and postural orthostatic tachycardia.
Important Distinction
The hallmark of CFS/ME is post-exertional malaise (PEM) — if physical or mental exertion makes you disproportionately worse 12-72 hours later, CFS/ME should be strongly considered. If exercise generally makes you feel better (even if you are fatigued), the cause of your fatigue is more likely thyroid dysfunction, iron deficiency, depression, sleep apnea, or another treatable condition. Both scenarios benefit from the diagnostic testing and mitochondrial support covered in this guide.
The Energy Crisis
Your mitochondria are the power plants of every cell. CFS/ME patients have measurably impaired mitochondrial function — reduced ATP production, damaged electron transport chains, and depleted energy reserves. This is not abstract theory; it is measurable biology.
A landmark study by Myhill et al. (2009) found that mitochondrial function testing could distinguish CFS/ME patients from healthy controls with high sensitivity. Patients showed reduced ATP production, impaired ATP recycling (the rate at which ADP converts back to ATP), and evidence of mitochondrial membrane damage. The degree of mitochondrial dysfunction correlated directly with symptom severity.
Think of it this way: a healthy person's mitochondria are like a fully charged battery that recharges quickly. A CFS/ME patient's mitochondria are like a damaged battery with reduced capacity that charges slowly. Every activity draws from a smaller energy pool, and recovery (recharging) takes far longer. The following targets address every stage of mitochondrial energy production.
Role: Essential electron carrier in Complex III of the electron transport chain. Transfers electrons from Complex I/II to Complex III. Also a potent lipid-soluble antioxidant that protects mitochondrial membranes from oxidative damage.
In CFS/ME: Multiple studies show significantly lower plasma CoQ10 levels in CFS/ME patients compared to controls. Correlates directly with symptom severity.
Dose: 200-400 mg ubiquinol (reduced form) daily with fat-containing meals. Superior absorption vs ubiquinone.
Role: Central coenzyme in cellular energy metabolism. Required for glycolysis, the TCA cycle, and oxidative phosphorylation. Also critical for DNA repair via PARP enzymes and sirtuins (longevity genes).
In CFS/ME: NAD+ levels decline with age and chronic illness. CFS/ME patients show impaired NAD+/NADH ratios and reduced oxidative phosphorylation capacity.
Dose: NMN (250-500 mg) or NR (300-600 mg) daily as NAD+ precursors. Sublingual NMN may offer faster absorption.
Role: A 5-carbon sugar that is the backbone of ATP, ADP, and AMP molecules. The rate-limiting substrate for de novo ATP synthesis via the pentose phosphate pathway. Especially critical when ATP pools are depleted.
In CFS/ME: CFS/ME patients have measurably depleted ATP pools. D-ribose supplementation bypasses the slow de novo synthesis pathway and directly replenishes the adenine nucleotide pool.
Dose: 5 g three times daily (15 g total) for the first 3-4 weeks, then reduce to 5 g twice daily for maintenance.
Role: Stimulates mitochondrial biogenesis — the creation of entirely new mitochondria. Activates PGC-1alpha, the master regulator of mitochondrial production. Also provides potent antioxidant protection (5,000x more redox cycles than vitamin C).
In CFS/ME: Not a classical deficiency nutrient, but CFS/ME patients have reduced mitochondrial density and function. PQQ addresses this by growing new, healthy mitochondria rather than repairing damaged ones.
Dose: 10-20 mg daily. Pairs synergistically with CoQ10 — PQQ builds new mitochondria, CoQ10 fuels them.
Role: Transports long-chain fatty acids across the inner mitochondrial membrane into the matrix for beta-oxidation. Without carnitine, fat cannot be burned for energy. The acetyl group also supports acetylcholine production (neurotransmitter for focus and memory).
In CFS/ME: CFS/ME patients frequently show reduced serum carnitine and impaired fatty acid oxidation. This forces greater reliance on glucose metabolism — a less efficient energy pathway.
Dose: 1,000-2,000 mg daily in divided doses. Take in the morning and early afternoon (can be stimulating). Avoid late dosing.
Role: Cofactor for ATP production — ATP actually exists as Mg-ATP in the cell. Required for over 600 enzymatic reactions including every step of the electron transport chain. Also critical for muscle relaxation and nervous system regulation.
In CFS/ME: Up to 50% of the population is deficient. Serum magnesium is unreliable — RBC magnesium is the accurate measure. CFS/ME patients consistently show depleted intracellular magnesium.
Dose: 300-400 mg elemental magnesium daily. Glycinate for calming/sleep, malate for energy/muscles, threonate for brain. Avoid oxide form.
The Stress System
The hypothalamic-pituitary-adrenal (HPA) axis is your central stress response system. In CFS/ME, it doesn't simply become 'fatigued' — it becomes dysregulated, producing too little cortisol at the wrong times and losing the normal diurnal rhythm.
The outdated term “adrenal fatigue” oversimplifies what actually happens. Your adrenal glands are rarely the problem — the dysfunction occurs at the hypothalamic and pituitary level in the brain. After prolonged stress (physical, emotional, infectious, or environmental), the HPA axis downregulates its output as a protective mechanism. Cortisol — which is essential for energy, immune regulation, blood sugar stability, and stress tolerance — becomes chronically low, especially in the morning when you need it most.
This is not a linear progression from “too much cortisol” to “too little.” The stages below represent a general pattern, but individual presentations vary. Testing (4-point salivary cortisol and DUTCH test) reveals your specific pattern and guides treatment.
Symptoms: Anxiety, racing heart, difficulty sleeping, hypervigilance, elevated energy followed by crashes. Body producing excess cortisol in response to perceived threat.
Duration: Days to weeks under acute stress
Management: Stress reduction, breathwork, adequate sleep, magnesium supplementation. Limit caffeine. This stage is protective and appropriate for genuine acute threats.
Symptoms: Fatigue despite adequate sleep, afternoon energy crashes, difficulty concentrating, increased illness frequency, disrupted circadian cortisol curve (high at night, low in morning — the reverse of healthy patterns).
Duration: Weeks to months of ongoing stress
Management: Adaptogens (ashwagandha, rhodiola), sleep optimization, circadian light exposure, moderate (not intense) exercise, nutrient repletion (B vitamins, vitamin C, magnesium).
Symptoms: Profound fatigue, inability to handle any stress, orthostatic intolerance, brain fog, exercise intolerance, salt and sugar cravings, immune dysfunction, worsening of all symptoms with exertion.
Duration: Months to years — characteristic of CFS/ME
Management: Gentle adrenal support, phosphatidylserine, licorice root (in low-cortisol cases only), light therapy for circadian reset, activity pacing, staged recovery protocol. Aggressive interventions are counterproductive at this stage.
Adaptogens for HPA Support
Adaptogens like ashwagandha, rhodiola, eleuthero, and holy basil help normalize HPA axis output — they raise cortisol when it is too low and reduce it when it is too high. They are modulators, not stimulants. For CFS/ME patients in Stage 3 (blunted cortisol), adaptogens are most effective after foundational nutrient repletion (B vitamins, vitamin C, magnesium) and sleep optimization. See the Adaptogens Guide and Adrenal Health Guide for detailed protocols.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
Immune Dysfunction
CFS/ME is increasingly understood as a neuroimmune disease. The immune system is not simply weak — it is chronically activated and dysregulated, consuming enormous energy while failing to resolve the underlying problem.
Consistently the most replicated finding in CFS/ME research. NK cells show reduced cytotoxic activity — their ability to kill virus-infected cells and cancer cells is measurably impaired. This may explain the persistent viral reactivation and increased susceptibility to infections seen in CFS/ME patients.
References: Brenu et al., 2011; Maher et al., 2005; Fletcher et al., 2010
Increased levels of pro-inflammatory cytokines including IL-1beta, IL-6, TNF-alpha, and interferon-gamma have been documented in CFS/ME patients. These cytokines directly cause fatigue, brain fog, pain, and malaise — the 'sickness behavior' response. Importantly, cytokine elevation may be intermittent, appearing during relapses and PEM crashes.
References: Montoya et al., 2017; Hornig et al., 2015
CD8+ T-cells in CFS/ME patients show markers of chronic activation and exhaustion — similar to what is seen in chronic viral infections. This suggests the immune system is perpetually engaged in fighting something, depleting T-cell reserves and impairing adaptive immune responses.
References: Curriu et al., 2013; Hardcastle et al., 2015
A subset of CFS/ME patients show autoantibodies against adrenergic and muscarinic receptors (which regulate autonomic nervous system function). This may explain the orthostatic intolerance, heart rate abnormalities, and autonomic dysfunction common in CFS/ME. The autoimmune hypothesis is supported by the frequent post-infectious onset of CFS/ME.
References: Loebel et al., 2016; Scheibenbogen et al., 2018
The immune dysfunction in CFS/ME creates a vicious cycle: chronic immune activation consumes massive amounts of ATP (the immune system is the most energy-demanding system in the body after the brain), further depleting already-impaired mitochondria. This is why mitochondrial support and immune modulation must proceed simultaneously. Supporting immune regulation through gut health restoration, adequate sleep, stress management, and targeted supplementation (vitamin D, zinc, quercetin, medicinal mushrooms) is a critical component of the recovery protocol.
Where Energy Comes From
Understanding how your body produces energy reveals exactly where CFS/ME disrupts the process — and where targeted supplements and interventions can restore function.
In CFS/ME: CFS/ME patients often rely more heavily on glycolysis due to impaired oxidative phosphorylation. This is far less efficient — producing only 2 ATP vs 36 from full mitochondrial metabolism. Leads to excess lactate production, explaining the muscle pain and rapid fatigue.
Nutritional support: D-ribose (ATP backbone), B1/thiamine (pyruvate dehydrogenase), adequate glucose availability, magnesium
In CFS/ME: Organic acid testing in CFS/ME patients frequently shows elevated or abnormal TCA cycle intermediates (citrate, succinate, malate, fumarate), suggesting enzyme dysfunction or bottlenecks in the cycle.
Nutritional support: B-vitamins (B1, B2, B3, B5 are all TCA cycle cofactors), alpha-lipoic acid, CoQ10, magnesium, iron
In CFS/ME: The primary site of dysfunction in CFS/ME. Studies show reduced Complex I, III, and IV activity, impaired electron flow, increased ROS production, and reduced total ATP output. This is where most mitochondrial support supplements target.
Nutritional support: CoQ10 (Complex III), NADH/NAD+ (Complex I), iron and copper (Complex IV), cardiolipin support, antioxidants to protect against ETC-generated ROS
In CFS/ME: CFS/ME patients show impaired fatty acid oxidation, forcing greater dependence on glucose. This explains the carbohydrate cravings, blood sugar instability, and rapid energy depletion. L-carnitine deficiency is a common bottleneck.
Nutritional support: Acetyl-L-carnitine (fatty acid transport), CoQ10, adequate B2 (riboflavin), pantothenic acid (B5 for CoA)
A healthy person recycles their body weight in ATP every single day — roughly 40-70 kg of ATP is produced, used, and regenerated daily. The body only holds about 250 g of ATP at any moment; it is the speed of recycling that determines energy capacity. In CFS/ME, this recycling is impaired: ATP breaks down to ADP and AMP normally, but the regeneration of AMP back to ATP is slowed. When ATP demand exceeds recycling capacity, AMP degrades further to IMP and eventually hypoxanthine — which is excreted in urine and lost. This is why CFS/ME patients cannot simply “push through” fatigue: they are literally losing the building blocks of their energy currency. D-ribose supplementation addresses this by providing the substrate for de novo ATP synthesis to rebuild the depleted nucleotide pool.
Restorative Rest
Unrefreshing sleep is a core diagnostic criterion of CFS/ME. Standard sleep hygiene advice is necessary but insufficient — CFS patients need targeted strategies to address the specific sleep architecture disruptions found in this condition.
CFS/ME patients frequently have alpha-wave intrusion during deep (delta) sleep — the brain produces waking-type brain waves during what should be restorative deep sleep. This explains unrefreshing sleep even after 8-10 hours. Strategies to improve deep sleep: magnesium glycinate (300-400 mg) before bed, glycine (3 g), low-dose melatonin (0.3-0.5 mg — not high-dose), and cool room temperature (60-67F).
Many CFS/ME patients have disrupted circadian rhythm with delayed sleep phase (falling asleep late, waking late). Reset with: consistent wake time (even on weekends), 10-20 min bright light within 30 min of waking, dim light and blue-blocking glasses after sunset, no screens 1 hour before bed. Melatonin (0.3-0.5 mg) 30-60 min before desired bedtime can help shift the phase.
Orthostatic intolerance and POTS (common CFS/ME comorbidities) disrupt sleep through nighttime heart rate variability and adrenaline surges. Strategies: elevate head of bed 6-10 inches (reduces nighttime renin-angiotensin activation), increase salt intake (2-3 g sodium from sea salt before bed), compression stockings during the day, and adequate hydration throughout the day.
Many CFS/ME patients have comorbid fibromyalgia or widespread pain that disrupts sleep. Non-pharmacological approaches: magnesium glycinate (muscle relaxation), Epsom salt baths before bed, gentle stretching, low-dose CBD oil (if legal and tolerated), and appropriate mattress support. Avoid NSAIDs chronically — they damage the gut lining.
Standard sleep hygiene advice (cool, dark, quiet room) applies, but CFS/ME patients benefit from additional measures: extended sleep window (9-10 hours in bed to compensate for poor sleep quality), scheduled rest periods during the day (but not long naps that fragment nighttime sleep), consistent pre-sleep routine starting 60-90 minutes before bed, and avoiding mentally demanding activity within 2 hours of bedtime.
For a comprehensive deep dive into sleep optimization, see the Complete Sleep Guide and Sleep Environment Guide.
Activity Management
The most important behavioral intervention for CFS/ME is activity pacing — not graded exercise therapy (GET). Understanding why matters for your recovery.
Graded Exercise Therapy (GET) was once the standard recommendation for CFS/ME based on the 2011 PACE trial. However, extensive independent reanalysis revealed critical methodological flaws: the trial lowered recovery thresholds mid-study, used subjective outcomes, and had no objective measures of fitness improvement. When independent researchers reanalyzed the PACE data using the original (pre-change) recovery criteria, the recovery rate dropped from 22% to just 7% — no better than the control group.
In response, NICE (UK National Institute for Health and Care Excellence) removed GET from its CFS/ME guidelines in 2021. The CDC had already softened its stance. Multiple patient surveys consistently show that forced incremental exercise worsens symptoms in 50-74% of CFS/ME patients. The biology makes sense: if mitochondria are dysfunctional and ATP recycling is impaired, forcing increased energy demand does not build capacity — it deepens the energy deficit.
The safer and more effective approach is activity pacing using the energy envelope concept. Your energy envelope is the amount of physical, cognitive, and emotional activity you can sustain without triggering post-exertional malaise (PEM) in the following 24-72 hours.
Track for 2 weeks: Log all activities (physical, cognitive, social), their duration and intensity, and any PEM episodes that follow. Note the delay between activity and crash.
Use a heart rate monitor: Determine your anaerobic threshold (AT). For CFS/ME patients, this is often 50-60% of predicted max heart rate. A simple formula: (220 - age) x 0.55. Stay below this number during all activity.
Plan rest periods proactively: Schedule rest before activity (pre-rest), during activity (micro-breaks), and after activity (recovery rest). Do not wait until you are exhausted — by then, you have already exceeded your envelope.
Stabilize before expanding: Once you can consistently stay within your envelope for 2-4 weeks without PEM, cautiously increase activity by 5-10%. If PEM returns, drop back to the previous level and stabilize again.
Account for all energy costs: Physical activity, cognitive effort (work, reading, conversations), emotional stress, and sensory stimulation (noise, light, crowds) all draw from the same energy pool. A mentally exhausting day requires the same recovery as a physically demanding one.
The Gut-Energy Axis
The gut is not just for digestion — it is the primary interface between your immune system and the outside world. In CFS/ME, gut dysfunction is both a contributor and a consequence.
Research consistently shows that CFS/ME patients have significantly altered gut microbiome composition: reduced diversity, lower levels of butyrate-producing bacteria (especially Faecalibacterium prausnitzii), and increased intestinal permeability. When the gut barrier is compromised, bacterial lipopolysaccharide (LPS) — a potent endotoxin — leaks into the bloodstream. LPS activates toll-like receptor 4 (TLR4) on immune cells, triggering a cascade of inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) that directly cause fatigue, brain fog, and malaise.
The 4R gut protocol addresses this systematically. For a comprehensive deep dive, see the Gut Health Guide and Gut Healing Guide.
Targeted Support
These supplements target the specific biological dysfunctions identified in CFS/ME: mitochondrial impairment, HPA axis dysregulation, nutrient depletion, and immune dysregulation. Introduce them gradually — not all at once.
Essential component of the mitochondrial electron transport chain (Complex III). Directly improves ATP production capacity. Also the most potent lipid-soluble antioxidant in mitochondrial membranes, protecting against oxidative damage. Castro-Marrero et al. (2014) demonstrated significant fatigue reduction in CFS/ME patients with CoQ10 + NADH.
Use ubiquinol form (reduced) — absorbs 3-8x better than ubiquinone. Always take with a fat-containing meal. May take 4-8 weeks for full effect. Statin users are especially at risk of deficiency.
Directly replenishes depleted ATP pools by providing the ribose backbone for adenine nucleotide synthesis. Bypasses the slow de novo pathway. Teitelbaum et al. (2006) found 66% of CFS/fibromyalgia patients reported significant improvement in energy, sleep, mental clarity, and overall well-being with D-ribose supplementation.
Dissolves in water, slightly sweet. Take with meals to prevent blood sugar dips. Can be mixed into smoothies or coffee. Start at full dose for 3-4 weeks, then reduce to maintenance.
Replenishes cellular NAD+ levels critical for mitochondrial energy production, DNA repair, and sirtuin activation. NAD+ is consumed in energy metabolism and declines with age and chronic illness. Boosting NAD+ improves oxidative phosphorylation efficiency and cellular stress resilience. NMN converts to NAD+ via the salvage pathway.
Sublingual NMN may provide faster absorption. Take in the morning — can be activating. Store in cool, dry conditions. NR (Niagen) has more published human trials; NMN is gaining evidence rapidly.
B vitamins are essential cofactors in every step of energy metabolism. B1 (thiamine) is required for pyruvate dehydrogenase (gateway to TCA cycle). B2 (riboflavin) is a component of FAD (electron transport chain). B3 (niacin) is the precursor to NAD+. B5 (pantothenic acid) is required for CoA synthesis. B6 is needed for amino acid metabolism and neurotransmitter synthesis. B12 and folate support methylation and red blood cell production.
Use methylated forms: methylfolate (not folic acid), methylcobalamin (not cyanocobalamin), P-5-P (active B6). MTHFR gene variants (common in CFS/ME) impair folate and B12 metabolism — methylated forms bypass this. Start at half dose if sensitive.
ATP exists as Mg-ATP — magnesium is literally required for cellular energy currency to function. Cofactor for 600+ enzymatic reactions. Supports muscle relaxation, nervous system regulation, sleep quality (via GABA modulation), and mitochondrial function. Deficiency is endemic (50%+ of population) and especially common in CFS/ME.
Glycinate for evening (calming, supports sleep). Malate for morning (supports energy production, pairs with malic acid for TCA cycle). Threonate for cognitive support. Avoid oxide form. Split dosing for better absorption.
Transports fatty acids into mitochondria for beta-oxidation. CFS/ME patients show impaired fatty acid transport and reduced serum carnitine. ALCAR supplementation restores fat-burning capacity and provides the acetyl group for acetylcholine synthesis (cognitive function). Multiple studies show reduced fatigue and improved mental clarity in CFS/ME populations.
Take morning and early afternoon — can be mildly stimulating. Avoid evening dosing. May have a slight fishy odor (normal). L-carnitine tartrate is an alternative if ALCAR feels too stimulating.
Premier adaptogen for HPA axis modulation. Reduces cortisol by 28% in clinical trials (Chandrasekhar et al., 2012). Normalizes the cortisol awakening response. Also improves thyroid function markers (T3, T4) — relevant as subclinical hypothyroidism frequently coexists with CFS/ME. Enhances GABAergic activity for stress resilience and sleep quality.
KSM-66 is the most studied extract. Take with meals. Can be taken morning (for stress resilience) or evening (for sleep). May increase thyroid hormones — monitor if on thyroid medication. Avoid if nightshade-sensitive.
Unique among supplements: PQQ stimulates mitochondrial biogenesis through PGC-1alpha activation — literally growing new mitochondria. This is critical for CFS/ME, where both mitochondrial number and function are compromised. Also provides exceptional antioxidant protection with 5,000x more redox cycling capacity than vitamin C.
Take with CoQ10 for synergistic effect — PQQ builds new mitochondria, CoQ10 ensures they function optimally. Small molecule, well-absorbed. Some people report vivid dreams. Best taken in the morning.
Introduction Order Matters
Do not start all supplements at once. CFS/ME patients are often hypersensitive to new inputs. Start with magnesium and B-vitamins (foundational). After 2 weeks, add D-ribose and CoQ10 (energy). After another 2-4 weeks, introduce adaptogens (HPA support). Finally, add NAD+ precursors and PQQ (mitochondrial biogenesis). Start each at half dose and increase to full dose over 1-2 weeks. This staged approach minimizes adverse reactions and allows you to identify which supplements are helping. See the B-Vitamins Guide and CoQ10 Guide for more detail.
Diagnostic Workup
You cannot fix what you do not measure. This diagnostic panel goes beyond standard labs to identify the specific dysfunctions driving your fatigue. Print this list and bring it to your doctor.
Morning cortisol level drawn between 7-9 AM (fasting). Reflects peak HPA axis output.
Standard Range
6-23 mcg/dL
Optimal Target
12-18 mcg/dL at 8 AM
Low AM cortisol suggests HPA axis blunting — characteristic of stage 3 adrenal dysfunction in CFS/ME. High AM cortisol with low PM cortisol is the healthy pattern.
Saliva samples at waking, noon, 5 PM, and bedtime. Maps the full diurnal cortisol curve.
Standard Range
Varies by lab — pattern matters more than absolute values
Optimal Target
High morning, steady decline through day, lowest at bedtime
CFS/ME patients commonly show a flattened curve (low throughout) or inverted pattern (low morning, elevated evening). This test reveals dysregulation invisible on a single blood draw.
TSH, Free T3, Free T4, Reverse T3, and thyroid antibodies (TPO-Ab, TG-Ab).
Standard Range
TSH 0.5-4.5 mIU/L (standard range)
Optimal Target
TSH 1.0-2.0, Free T3 3.0-4.0 pg/mL, Reverse T3 < 15 ng/dL, RT3:FT3 ratio < 10
Standard TSH alone misses subclinical hypothyroidism. Reverse T3 elevation (from chronic stress/illness) blocks T3 action even when TSH and T4 appear normal. Hashimoto's antibodies indicate autoimmune thyroid disease.
Serum iron, ferritin, TIBC (total iron-binding capacity), transferrin saturation.
Standard Range
Ferritin 12-150 ng/mL (female), 12-300 ng/mL (male)
Optimal Target
Ferritin 50-100 ng/mL (minimum for energy), iron saturation 25-45%
Ferritin below 50 causes fatigue even though lab reference ranges start at 12. Iron is required for oxygen transport (hemoglobin), mitochondrial electron transport chain (cytochrome c), and energy enzyme function.
Serum B12 plus methylmalonic acid (MMA). Serum folate or RBC folate.
Standard Range
B12 200-900 pg/mL
Optimal Target
B12 > 600 pg/mL, MMA < 270 nmol/L
Serum B12 can be falsely normal while functional B12 (measured by MMA) is deficient. B12 is essential for methylation, nerve function, and red blood cell production. Deficiency causes fatigue, brain fog, and neuropathy.
25-hydroxyvitamin D — the storage form that reflects true vitamin D status.
Standard Range
30-100 ng/mL
Optimal Target
50-80 ng/mL
Vitamin D regulates 1,000+ genes including immune function and mitochondrial activity. Deficiency (below 30 ng/mL) is extremely common in CFS/ME and contributes to immune dysregulation, muscle weakness, and fatigue.
Magnesium measured inside red blood cells — reflects true intracellular status.
Standard Range
4.2-6.8 mg/dL
Optimal Target
5.5-6.5 mg/dL
Serum magnesium (the standard test) only reflects 1% of body magnesium and remains normal until severe depletion. RBC magnesium reveals the intracellular deficiency present in most CFS/ME patients. Critical for Mg-ATP energy production.
High-sensitivity C-reactive protein and erythrocyte sedimentation rate — general inflammatory markers.
Standard Range
hs-CRP < 3.0 mg/L, ESR < 20 mm/hr
Optimal Target
hs-CRP < 0.5 mg/L, ESR < 10 mm/hr
Chronic low-grade inflammation is common in CFS/ME. Elevated hs-CRP suggests systemic inflammatory activation. Used as a baseline marker and to track protocol effectiveness over time.
Urine metabolites reflecting mitochondrial function, neurotransmitter metabolism, gut dysbiosis, and nutrient status.
Standard Range
Reference ranges vary by marker
Optimal Target
All markers within functional ranges
The most comprehensive single test for CFS/ME. Reveals mitochondrial dysfunction (elevated citric acid cycle intermediates), B-vitamin deficiency, CoQ10 need, neurotransmitter imbalances, and fungal/bacterial overgrowth markers. Available through specialty labs like Great Plains/Mosaic Diagnostics.
The Roadmap
Recovery from chronic fatigue is not linear — it is a staged process that rebuilds energy systems from the ground up. Rushing leads to setbacks. Each phase builds on the previous one. Move to the next phase only when you have achieved baseline stability for 2-4 weeks.
Test, correct deficiencies, stabilize sleep, establish pacing
Mitochondrial support, gut repair, gentle movement expansion
Advanced mitochondrial biogenesis, cautious hormesis, expand activity
Full protocol integration, expanded capacity, long-term resilience
Non-Linear Recovery
Recovery from chronic fatigue is rarely a straight upward line. Expect setbacks, plateaus, and fluctuations. A “two steps forward, one step back” pattern is normal. Track your overall trend over months, not days. If a phase causes PEM or worsening, drop back to the previous phase and stabilize before trying again. Patience is not optional — it is the protocol.
Common Questions
Evidence-based answers to the most common questions about chronic fatigue, CFS/ME, mitochondrial support, and recovery protocols.
Adrenal Support
HPA axis recovery, cortisol optimization, and adaptogen protocols for stress resilience.
Longevity
Deep dive into NAD+ biology, NMN vs NR, dosing, and mitochondrial energy restoration.
Mitochondrial
Ubiquinol vs ubiquinone, electron transport chain support, and clinical dosing protocols.
This guide gives you the science. A CryoCove coach gives you the personalization — analyzing your lab results, symptom patterns, energy envelope, and lifestyle to design a staged recovery protocol tailored to YOUR specific situation. Testing guidance, supplement sequencing, pacing strategies, and ongoing accountability as your energy rebuilds.